CONRAD
Abenan Louise Ouattara Yao, PhD, serves as a Research Fellow at CONRAD since January 2014, focusing on the identification and development of microbicides against HIV and contraceptives, as well as vaccine technology for HIV prevention. Prior to this role, Abenan worked as a Postdoctoral Research Fellow at the Population Council from July 2010 to December 2013, studying the effects of zinc in mucosal HIV transmission and establishing infection models using human and macaque tissues. Abenan's career began as a PhD student at bioMerieux from October 2006 to January 2010, where the characterization of a new reovirus strain and the development of a molecular detection test were key contributions. Abenan holds a PhD in Biology-Virology from Claude Bernard University, along with two master's degrees in Biotechnology and Healthcare, and a Bachelor's degree in Chemistry.
CONRAD
1 followers
CONRAD is a non-profit biomedical R&D organization with a social mission, to improve global health through the development of innovative, user-centered technologies. We exist to facilitate the rapid preclinical-to-clinical development of safe, acceptable, affordable products and biomedical interventions that help to fill unmet women's and men's health needs globally. Our work does not begin in the laboratory or even in the scientist's mind, but with the needs of women and men everywhere who are struggling for a better life for themselves and their families. As a multifaceted organization involved in all aspects of product development, we place high priority on those needs, doing much of our work in real settings, with real people. Our broad scope, global network and focus on reproductive health enables us to help to ensure that the emerging and changing needs of women and men in under-resourced parts of the world are acted on in swift and prudent ways.